Cargando…
A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis
BACKGROUND: Lung adenocarcinoma (LUAD) patients experiencing lymph node metastasis (LNM) always exhibit poor clinical outcomes. A biomarker or gene signature that could predict survival in these patients would have a substantial clinical impact, allowing for earlier detection of mortality risk and f...
Autores principales: | Wang, Yanfang, Zhang, Quanli, Gao, Zhaojia, Xin, Shan, Zhao, Yanbo, Zhang, Kai, Shi, Run, Bao, Xuanwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469135/ https://www.ncbi.nlm.nih.gov/pubmed/31015800 http://dx.doi.org/10.1186/s12935-019-0822-1 |
Ejemplares similares
-
Expression profile analysis identifies IER3 to predict overall survival and promote lymph node metastasis in tongue cancer
por: Xiao, Fang, et al.
Publicado: (2019) -
Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Yanfang, et al.
Publicado: (2019) -
Identification of the miRNA signature and key genes in colorectal cancer lymph node metastasis
por: Wang, Xi, et al.
Publicado: (2021) -
A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)
por: Al-Dherasi, Aisha, et al.
Publicado: (2021) -
A novel epigenetic signature for overall survival prediction in patients with breast cancer
por: Bao, Xuanwen, et al.
Publicado: (2019)